Search Results - "Caguioa, P B"

Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial by Chan, A.T.C., Lee, V.H.F., Hong, R.-L., Ahn, M.-J., Chong, W.Q., Kim, S.-B., Ho, G.F., Caguioa, P.B., Ngamphaiboon, N., Ho, C., Aziz, M.A.S.A., Ng, Q.S., Yen, C.-J., Soparattanapaisarn, N., Ngan, R.K.-C., Kho, S.K., Tiambeng, M.L.A., Yun, T., Sriuranpong, V., Algazi, A.P., Cheng, A., Massarelli, E., Swaby, R.F., Saraf, S., Yuan, J., Siu, L.L.

“…Pembrolizumab previously demonstrated robust antitumor activity and manageable safety in a phase Ib study of patients with heavily pretreated, programmed death…”
Get full text

Chronic lymphocytic leukemia by Caguioa, P B, Tansan, S, McCaffrey, R P

Get more information

Treatment of advanced non-small cell lung cancer with very high-dose cisplatin combined with etoposide and mitomycin C by Hesketh, P J, Tansan, S, Caguioa, P B, Hesketh, A, Blanchard, R, DiMartino, N, Carney, D

“…Treatment options for advanced non-small-cell lung cancer are inadequate. There remains a critical need for more effective systemic therapies. Forty-one…”
Get more information

Breast cancer ErbB2 status in Asian women: A review of local literature by Tan, Y., Han, S., Lu, Y., Yip, C. H., Sunpaweravong, P., Jeong, J., Caguioa, P. B., Aggarwal, S., Yeoh, E. M., Moon, H.

“…Abstract only e22164 Background: Breast cancer incidence is increasing throughout Asia. However, the characteristics of Asian breast cancer are not always well…”
Get full text